nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—ABCB1—adrenal gland cancer	0.979	1	CbGaD
Buspirone—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00122	0.201	CbGeAlD
Buspirone—HTR2A—vein—adrenal gland cancer	0.00114	0.188	CbGeAlD
Buspirone—HTR2A—urine—adrenal gland cancer	0.000668	0.11	CbGeAlD
Buspirone—CYP3A4—urine—adrenal gland cancer	0.000618	0.102	CbGeAlD
Buspirone—CYP2D6—urine—adrenal gland cancer	0.000608	0.1	CbGeAlD
Buspirone—HTR2B—adrenal cortex—adrenal gland cancer	0.000331	0.0546	CbGeAlD
Buspirone—HTR2B—adrenal gland—adrenal gland cancer	0.000239	0.0394	CbGeAlD
Buspirone—DRD2—pituitary gland—adrenal gland cancer	0.000217	0.0358	CbGeAlD
Buspirone—HTR1A—adrenal gland—adrenal gland cancer	0.000214	0.0353	CbGeAlD
Buspirone—HTR2A—gonad—adrenal gland cancer	0.000146	0.0242	CbGeAlD
Buspirone—HTR2A—pituitary gland—adrenal gland cancer	0.000143	0.0236	CbGeAlD
Buspirone—HTR2A—adrenal gland—adrenal gland cancer	0.000128	0.0211	CbGeAlD
Buspirone—ABCB1—adrenal cortex—adrenal gland cancer	0.000116	0.0191	CbGeAlD
Buspirone—ABCB1—gonad—adrenal gland cancer	9.6e-05	0.0158	CbGeAlD
Buspirone—ABCB1—pituitary gland—adrenal gland cancer	9.36e-05	0.0155	CbGeAlD
Buspirone—ABCB1—adrenal gland—adrenal gland cancer	8.37e-05	0.0138	CbGeAlD
Buspirone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.73e-05	0.00399	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	5.71e-05	0.00398	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—GNRH1—adrenal gland cancer	5.62e-05	0.00392	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—GNRHR—adrenal gland cancer	5.57e-05	0.00388	CbGpPWpGaD
Buspirone—HTR1A—G alpha (i) signalling events—GNAS—adrenal gland cancer	5.57e-05	0.00388	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	5.39e-05	0.00376	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	5.3e-05	0.0037	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	5.09e-05	0.00355	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—TSHR—adrenal gland cancer	5.01e-05	0.00349	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	5.01e-05	0.00349	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	4.89e-05	0.00341	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	4.89e-05	0.00341	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—GNRHR—adrenal gland cancer	4.81e-05	0.00336	CbGpPWpGaD
Buspirone—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	4.8e-05	0.00334	CbGpPWpGaD
Buspirone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.64e-05	0.00324	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	4.53e-05	0.00316	CbGpPWpGaD
Buspirone—DRD3—G alpha (i) signalling events—POMC—adrenal gland cancer	4.3e-05	0.003	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—SDHB—adrenal gland cancer	4.29e-05	0.00299	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—GNRH1—adrenal gland cancer	4.22e-05	0.00294	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—GNAS—adrenal gland cancer	4.16e-05	0.0029	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—GNRH1—adrenal gland cancer	4.12e-05	0.00287	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—GNRHR—adrenal gland cancer	4.06e-05	0.00283	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—TSHR—adrenal gland cancer	4.04e-05	0.00282	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—GNAS—adrenal gland cancer	3.87e-05	0.0027	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—GNRH1—adrenal gland cancer	3.83e-05	0.00267	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GNRHR—adrenal gland cancer	3.78e-05	0.00263	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.77e-05	0.00263	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—TSHR—adrenal gland cancer	3.76e-05	0.00262	CbGpPWpGaD
Buspirone—HTR1A—G alpha (i) signalling events—POMC—adrenal gland cancer	3.75e-05	0.00261	CbGpPWpGaD
Buspirone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	3.74e-05	0.00261	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	3.71e-05	0.00259	CbGpPWpGaD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.68e-05	0.00256	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	3.68e-05	0.00256	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—TSHR—adrenal gland cancer	3.67e-05	0.00256	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ZNRF3—adrenal gland cancer	3.55e-05	0.00247	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.51e-05	0.00245	CbGpPWpGaD
Buspirone—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	3.47e-05	0.00242	CbGpPWpGaD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.42e-05	0.00239	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—TSHR—adrenal gland cancer	3.41e-05	0.00238	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	3.37e-05	0.00235	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	3.34e-05	0.00233	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ZNRF3—adrenal gland cancer	3.3e-05	0.0023	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	3.29e-05	0.0023	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	3.29e-05	0.00229	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	3.28e-05	0.00228	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	3.23e-05	0.00225	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	3.21e-05	0.00224	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	3.18e-05	0.00221	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—SDHB—adrenal gland cancer	3.1e-05	0.00216	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.06e-05	0.00213	CbGpPWpGaD
Buspirone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	3.03e-05	0.00212	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.98e-05	0.00208	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	2.98e-05	0.00207	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	2.96e-05	0.00206	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	2.93e-05	0.00204	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	2.91e-05	0.00203	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	2.89e-05	0.00201	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	2.88e-05	0.00201	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	2.88e-05	0.00201	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	2.88e-05	0.00201	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	2.84e-05	0.00198	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	2.83e-05	0.00197	CbGpPWpGaD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	2.81e-05	0.00196	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—POMC—adrenal gland cancer	2.8e-05	0.00195	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—SDHD—adrenal gland cancer	2.76e-05	0.00193	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—RRM1—adrenal gland cancer	2.76e-05	0.00193	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.69e-05	0.00187	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.64e-05	0.00184	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—PRKACA—adrenal gland cancer	2.63e-05	0.00184	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.62e-05	0.00183	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	2.61e-05	0.00182	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	2.61e-05	0.00182	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—POMC—adrenal gland cancer	2.61e-05	0.00182	CbGpPWpGaD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.58e-05	0.0018	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	2.57e-05	0.00179	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	2.53e-05	0.00176	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	2.49e-05	0.00173	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	2.47e-05	0.00172	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	2.46e-05	0.00171	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—PRKACA—adrenal gland cancer	2.45e-05	0.00171	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	2.43e-05	0.0017	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	2.35e-05	0.00164	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—SDHB—adrenal gland cancer	2.34e-05	0.00163	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—TP53—adrenal gland cancer	2.32e-05	0.00161	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—CDC42—adrenal gland cancer	2.29e-05	0.0016	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	2.27e-05	0.00158	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GNRH1—adrenal gland cancer	2.26e-05	0.00158	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	2.23e-05	0.00156	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	2.22e-05	0.00155	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—SDHB—adrenal gland cancer	2.2e-05	0.00154	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—GNAS—adrenal gland cancer	2.19e-05	0.00152	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	2.17e-05	0.00151	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	2.14e-05	0.00149	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	2.13e-05	0.00149	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—CDC42—adrenal gland cancer	2.08e-05	0.00145	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SPRY2—adrenal gland cancer	2.07e-05	0.00144	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—MED12—adrenal gland cancer	2.06e-05	0.00144	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	2.04e-05	0.00142	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TSHR—adrenal gland cancer	2.02e-05	0.00141	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—SDHD—adrenal gland cancer	2e-05	0.00139	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—RRM1—adrenal gland cancer	2e-05	0.00139	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	1.99e-05	0.00139	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	1.99e-05	0.00139	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—GNAS—adrenal gland cancer	1.99e-05	0.00138	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	1.97e-05	0.00137	CbGpPWpGaD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	1.97e-05	0.00137	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	1.96e-05	0.00137	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.92e-05	0.00134	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	1.91e-05	0.00133	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MEN1—adrenal gland cancer	1.9e-05	0.00132	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	1.87e-05	0.00131	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	1.84e-05	0.00129	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	1.81e-05	0.00126	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	1.8e-05	0.00126	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	1.77e-05	0.00123	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	1.76e-05	0.00123	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	1.75e-05	0.00122	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.75e-05	0.00122	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	1.73e-05	0.00121	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	1.73e-05	0.00121	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	1.72e-05	0.0012	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.72e-05	0.0012	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	1.7e-05	0.00119	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	1.67e-05	0.00117	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	1.65e-05	0.00115	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	1.65e-05	0.00115	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	1.61e-05	0.00112	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	1.59e-05	0.00111	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	1.58e-05	0.0011	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	1.58e-05	0.0011	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	1.56e-05	0.00109	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	1.56e-05	0.00109	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	1.56e-05	0.00108	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	1.54e-05	0.00108	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	1.52e-05	0.00106	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	1.52e-05	0.00106	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.51e-05	0.00105	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.51e-05	0.00105	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	1.5e-05	0.00105	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	1.5e-05	0.00104	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—MED12—adrenal gland cancer	1.49e-05	0.00104	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	1.47e-05	0.00103	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	1.45e-05	0.00101	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	1.45e-05	0.00101	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	1.44e-05	0.001	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	1.44e-05	0.001	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	1.43e-05	0.000995	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—RRM1—adrenal gland cancer	1.42e-05	0.00099	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—SDHD—adrenal gland cancer	1.42e-05	0.00099	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.42e-05	0.000989	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.36e-05	0.000948	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	1.34e-05	0.000932	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	1.32e-05	0.00092	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	1.28e-05	0.000895	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	1.27e-05	0.000887	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	1.26e-05	0.000879	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	1.26e-05	0.000879	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	1.23e-05	0.000857	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	1.23e-05	0.000856	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—GNAS—adrenal gland cancer	1.22e-05	0.000849	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	1.2e-05	0.000833	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	1.18e-05	0.000825	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	1.17e-05	0.000818	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	1.17e-05	0.000812	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	1.14e-05	0.000798	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.14e-05	0.000796	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	1.13e-05	0.000785	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—MED12—adrenal gland cancer	1.12e-05	0.000783	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	1.11e-05	0.000773	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	1.11e-05	0.000772	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	1.09e-05	0.00076	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.09e-05	0.000757	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	1.07e-05	0.000746	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.06e-05	0.000738	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	1.06e-05	0.000738	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	1.03e-05	0.000719	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	1.02e-05	0.000713	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	1.02e-05	0.000713	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	1.01e-05	0.000702	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	9.97e-06	0.000695	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TERT—adrenal gland cancer	9.85e-06	0.000687	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	9.39e-06	0.000655	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	9.29e-06	0.000647	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	9.29e-06	0.000647	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	9.24e-06	0.000644	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	9.21e-06	0.000642	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	9.06e-06	0.000631	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	8.98e-06	0.000626	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	8.91e-06	0.000621	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	8.83e-06	0.000616	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	8.81e-06	0.000614	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	8.76e-06	0.00061	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	8.64e-06	0.000602	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	8.61e-06	0.000601	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	8.58e-06	0.000598	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—BAD—adrenal gland cancer	8.57e-06	0.000597	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	8.49e-06	0.000592	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	8.38e-06	0.000584	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—POMC—adrenal gland cancer	8.2e-06	0.000572	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PRKACA—adrenal gland cancer	8.2e-06	0.000572	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	8.13e-06	0.000566	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—POMC—adrenal gland cancer	7.9e-06	0.000551	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	7.8e-06	0.000544	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	7.73e-06	0.000539	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	7.56e-06	0.000527	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TERT—adrenal gland cancer	7.54e-06	0.000525	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	7.47e-06	0.000521	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	7.42e-06	0.000517	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—MED12—adrenal gland cancer	6.92e-06	0.000483	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	6.88e-06	0.00048	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	6.8e-06	0.000474	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GNAS—adrenal gland cancer	6.65e-06	0.000463	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	6.59e-06	0.000459	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—BAD—adrenal gland cancer	6.56e-06	0.000457	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	6.54e-06	0.000456	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	6.45e-06	0.00045	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	6.26e-06	0.000437	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	6.15e-06	0.000428	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	6.06e-06	0.000422	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—POMC—adrenal gland cancer	6.04e-06	0.000421	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	5.97e-06	0.000416	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	5.95e-06	0.000415	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—POMC—adrenal gland cancer	5.93e-06	0.000413	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	5.87e-06	0.000409	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	5.79e-06	0.000403	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	5.69e-06	0.000397	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	5.64e-06	0.000393	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.05e-06	0.000352	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.91e-06	0.000342	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	4.8e-06	0.000335	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	4.73e-06	0.00033	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—POMC—adrenal gland cancer	4.47e-06	0.000312	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	4.47e-06	0.000311	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	4.31e-06	0.000301	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.24e-06	0.000296	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—POMC—adrenal gland cancer	4.22e-06	0.000294	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.09e-06	0.000285	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	4.03e-06	0.000281	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.02e-06	0.00028	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	3.89e-06	0.000271	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—adrenal gland cancer	3.75e-06	0.000261	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—adrenal gland cancer	3.57e-06	0.000249	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	3.42e-06	0.000238	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	3.36e-06	0.000234	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	3.36e-06	0.000234	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	3.27e-06	0.000228	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—adrenal gland cancer	2.87e-06	0.0002	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	2.82e-06	0.000197	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.76e-06	0.000192	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.2e-06	0.000153	CbGpPWpGaD
